We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

29 hedge funds and large institutions have $75.8M invested in Protara Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

9% less funds holding

Funds holding: 32 → 29 (-3)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

18% less capital invested

Capital invested by funds: $93M → $75.8M (-$17.2M)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
29
Holders Change
-3
Holders Change %
-9.38%
% of All Funds
0.77%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
4
Increased
5
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$195K
2
DM
Deerfield Management
New York
+$162K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$113K
4
SIM
Spark Investment Management
New York
+$101K
5
Walleye Trading
Walleye Trading
New York
+$10.6K

Top Sellers

Rank Fund Capital Flow
1
TAM
Tiverton Asset Management
Delaware
-$2.95M
2
PP
Paloma Partners
Connecticut
-$234K
3
TC
TFS Capital
Pennsylvania
-$206K
4
Millennium Management
Millennium Management
New York
-$124K
5
Baird Financial Group
Baird Financial Group
Wisconsin
-$108K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$18.4M – – –
RCM
2
RA Capital Management
Massachusetts
$15.2M – – –
DM
3
Deerfield Management
New York
$14.7M +$162K +461 +1%
MAM
4
MPM Asset Management
Massachusetts
$9.18M – – –
DVC
5
Deer VII & Co
New York
$2.94M – – –
BBA
6
Baker Bros. Advisors
New York
$2.79M – – –
PA
7
Perceptive Advisors
New York
$2.51M -$52.8K -150 -2%
OFM
8
Omega Fund Management
Massachusetts
$2.33M – – –
Principal Financial Group
9
Principal Financial Group
Iowa
$1.72M -$10.9K -31 -0.7%
TAM
10
Tiverton Asset Management
Delaware
$1.51M -$2.95M -8,394 -67%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$1.47M – – –
Vanguard Group
12
Vanguard Group
Pennsylvania
$1.37M +$113K +320 +10%
BCM
13
Bridgeway Capital Management
Texas
$550K +$195K +554 +60%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$347K +$704 +2 +0.2%
BFA
15
BlackRock Fund Advisors
California
$209K -$704 -2 -0.4%
MPM
16
Meritage Portfolio Management
Kansas
$133K – – –
Northern Trust
17
Northern Trust
Illinois
$122K +$352 +1 +0.3%
KCM
18
Kornitzer Capital Management
Kansas
$112K – – –
PPCM
19
Pillar Pacific Capital Management
California
$107K – – –
SIM
20
Spark Investment Management
New York
$107K +$101K +288 New
Morgan Stanley
21
Morgan Stanley
New York
$24K -$4.22K -12 -15%
TRCT
22
Tower Research Capital (TRC)
New York
$18K -$3.87K -11 -19%
BA
23
BlackRock Advisors
Delaware
$13K – – –
BIM
24
BlackRock Investment Management
Delaware
$13K – – –
Walleye Trading
25
Walleye Trading
New York
$11K +$10.6K +30 New
1
2

TARA Hedge Fund Activity: Q3 2016 in Review

29 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q3 2016, worth a combined $75.8M — down 18% from $93M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of TARA and 4 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Bridgeway Capital Management, adding an estimated $195K. The largest seller was Tiverton Asset Management, cutting an estimated $2.95M.

  • 29 institutional investors held Protara Therapeutics (TARA) as of Q3 2016, down from 32 in Q2 2016.
  • Funds reported $75.8M of Protara Therapeutics stock for Q3 2016, down 18% quarter-over-quarter.
  • 4 funds opened new Protara Therapeutics positions in Q3 2016 and 7 closed out, a net change of -3 holders.
  • The largest Protara Therapeutics buyer in Q3 2016 was Bridgeway Capital Management, an estimated $195K added.
  • The largest Protara Therapeutics seller in Q3 2016 was Tiverton Asset Management, an estimated $2.95M sold.

Based on aggregated 13F filings for Q3 2016.